Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

OBJECTIVE: To compare the benefits and harms of drug treatments for adults with type 2 diabetes, adding non-steroidal mineralocorticoid receptor antagonists (including finerenone) and tirzepatide (a dual glucose dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agon...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qingyang, Nong, Kailei, Vandvik, Per Olav, Guyatt, Gordon H, Schnell, Oliver, Rydén, Lars, Marx, Nikolaus, Brosius, Frank C, Mustafa, Reem A, Agarwal, Arnav, Zou, Xinyu, Mao, Yunhe, Asadollahifar, Aminreza, Chowdhury, Saifur Rahman, Zhai, Chunjuan, Gupta, Sana, Gao, Ya, Lima, João Pedro, Numata, Kenji, Qiao, Zhi, Fan, Qinlin, Yang, Qinbo, Jin, Yinghui, Ge, Long, Yang, Qiuyu, Zhu, Hongfei, Yang, Fan, Chen, Zhe, Lu, Xi, He, Siyu, Chen, Xiangyang, Lyu, Xiafei, An, Xingxing, Chen, Yaolong, Hao, Qiukui, Standl, Eberhard, Siemieniuk, Reed, Agoritsas, Thomas, Tian, Haoming, Li, Sheyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077111/
https://www.ncbi.nlm.nih.gov/pubmed/37024129
http://dx.doi.org/10.1136/bmj-2022-074068

Ejemplares similares

Ejemplares similares